Global Prenatal DNA Sequencing Market Growth (Status and Outlook) 2025-2031

According to this study, the global Prenatal DNA Sequencing market size will reach US$ million by 2031.

DNA sequencing is the process used to determine the sequence of nucleotides within a DNA molecule.Prenatal DNA sequencing is a method of sequencing DNA isolated from the blood of a pregnant woman to reveal the complete genetic code of the fetus.Prenatal DNA sequencing is used to sequence the entire genome of an unborn baby, effectively detecting diseases or conditions such as down syndrome, cystic fibrosis, thalassemia and cancer.

United States market for Prenatal DNA Sequencing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Prenatal DNA Sequencing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Prenatal DNA Sequencing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Prenatal DNA Sequencing players cover BGI, Agilent Technologies, Roche, Illumina, LabCorp, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Prenatal DNA Sequencing Industry Forecast” looks at past sales and reviews total world Prenatal DNA Sequencing sales in 2024, providing a comprehensive analysis by region and market sector of projected Prenatal DNA Sequencing sales for 2025 through 2031. With Prenatal DNA Sequencing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Prenatal DNA Sequencing industry.

This Insight Report provides a comprehensive analysis of the global Prenatal DNA Sequencing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Prenatal DNA Sequencing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Prenatal DNA Sequencing market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Prenatal DNA Sequencing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Prenatal DNA Sequencing.

This report presents a comprehensive overview, market shares, and growth opportunities of Prenatal DNA Sequencing market by product type, application, key players and key regions and countries.

Segmentation by Type:
Genetic Disorders
Nonhereditary Disease

Segmentation by Application:
Hemophilia
Down Syndrome
Cystic Fibrosis
Autism
DiGeorge Syndrome
AIDS
Cancer
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
BGI
Agilent Technologies
Roche
Illumina
LabCorp
Natera
Twist Bioscience

Please note: The report will take approximately 2 business days to prepare and deliver. Show more